Abstract
The effects of (+-)-DOI (1-(2,5-dimethoxy-4-iodophenyl)-aminopropane) hydrochloride, a mixed 5-HT2A/2C receptor agonist, on the release of dopamine (DA) following D-amphetamine sulfate (AMP) or a DA D2 autoreceptor selective dose of (-)-apomorphine hydrochloride (APO), were investigated in rat striatum (STR) and nucleus accumbens (NAC), using in vivo microdialysis. AMP (1.0 mg/kg, s.c.) produced marked increases in extracellular DA levels in both the STR and the NAC whereas DOI (2.5 mg/kg, i.p.) alone had no significant effect on extracellular DA levels in either region. Pretreatment with DOI 30 min prior to AMP, further enhanced the AMP-induced increase in striatal extracellular DA levels. On the other hand, DOI pretreatment attenuated the APO (50 micrograms/kg, s.c.)-induced decrease in extracellular DA levels in the STR. Pretreatment with DOI did not affect the ability of either AMP or APO to modulate extracellular DA levels in the NAC. These results provide further evidence that 5-HT2A/2C receptors modulate the release mechanisms of DA in the STR. Possible mechanisms are discussed.
Citations
Jul 4, 2008·Psychopharmacology·Alice EgertonPaul M Grasby
Feb 2, 2013·PloS One·Bit Na KangP Sriramarao
May 20, 2000·Synapse·A GobertM J Millan
Oct 1, 2018·Reviews in the Neurosciences·Susanne NikolausHans-Wilhelm Müller
Jan 16, 2020·Neurotoxicity Research·John P Kostrzewa, Richard M Kostrzewa
Jun 11, 1998·Alcoholism, Clinical and Experimental Research·K T Szeliga, K A Grant
Mar 19, 1999·Journal of Neuroscience Research·N K NgP T Wong
Jan 1, 1997·Journal of Neural Transmission·N A DarmaniE L Elder
Feb 18, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ying QuStanley I Rapoport
Apr 16, 2003·Psychopharmacology·Danka Pericić
May 19, 2007·Psychopharmacology·Lucas SalomonJean-Pol Tassin
Nov 15, 2006·Psychopharmacology·M Olga Rojas-CorralesJuan A Mico
Mar 18, 2011·The Biochemical Journal·Zoë BarclayRory Mitchell
Aug 14, 2012·Synapse·Lara A PockrosJanet L Neisewander
Aug 14, 2020·International Journal of Molecular Sciences·Rahul BharatiyaPhilippe De Deurwaerdere
Mar 1, 1996·Psychopharmacology·H Y MeltzerP A Cola
Jan 26, 2000·Journal of Neurochemistry·G Lucas, U Spampinato
Oct 20, 2006·Psychopharmacology·S BodyE Szabadi
Jan 18, 2017·Psychopharmacology·Paul J FletcherAshlie D Soko
Jul 8, 2008·Psychopharmacology·Danuta Marona-LewickaDavid E Nichols
Dec 19, 2020·Neurotoxicity Research·Adam WojtasKrystyna Gołembiowska
Feb 22, 2012·Neuropharmacology·Paul J FletcherGuy A Higgins
Aug 10, 2012·The Journal of Experimental Biology·Jorge J Pérez-MaceiraManuel Aldegunde
Feb 6, 2004·Pharmacology & Therapeutics·David E Nichols
Aug 31, 2021·Frontiers in Neuroscience·Susanne NikolausHans-Wilhelm Müller